Helse Bergen HF

Address
Haukelandsveien 22

Sponsor Overview

assignment
26
sponsored trials
science
50
molecules
location_city
26
research centres
public
4
countries
person_search
99
investigators

Specializations

Oncology and Haematological Malignancies

Clinical research includes acute myeloid leukemia, high-risk myelodysplastic syndrome, breast cancer, pancreatic cancer, and recurrent grade IV glioma. The funded studies also address treatment response, resistance, and survival in aggressive cancer settings.

  • Acute myeloid leukemia
  • Breast cancer
  • Pancreatic cancer
  • Recurrent grade IV glioma

Research activity spans both solid tumours and blood cancers, with interest in personalised treatment strategies and disease control in difficult-to-treat malignancies.

Neurology and Neuroinflammatory Disease

Trials focus on multiple sclerosis, myalgic encephalomyelitis/chronic fatigue syndrome, and cluster headache, alongside studies in idiopathic sudden sensorineural hearing loss and long COVID. The portfolio also includes work on neuroregenerative and immune-related approaches in chronic neurological illness.

  • Multiple sclerosis
  • Myalgic encephalomyelitis/chronic fatigue syndrome
  • Chronic cluster headache
  • Idiopathic sudden sensorineural hearing loss

These studies reflect a strong interest in disabling neurological disorders, symptom burden, and functional recovery.

Gastroenterology, Endocrinology, and Ophthalmology

Research activity covers Crohn's disease, primary adrenal insufficiency, mild autonomous cortisol secretion, and thyroid eye disease. Trials also examine metabolic and hormonal outcomes relevant to endocrine disorders.

  • Crohn's disease
  • Primary adrenal insufficiency
  • Mild autonomous cortisol secretion
  • Thyroid eye disease

The sponsor supports clinical work across inflammatory bowel disease, adrenal disorders, cortisol excess, and orbital autoimmune disease.

Addiction Medicine and Psychiatric Metabolic Care

Studies include treatment for amphetamine dependence, benzodiazepine dependence, and comorbid dependence during opioid agonist therapy. Additional work addresses metabolic control in people using antipsychotic medication and weight-related outcomes in schizophrenia spectrum disorders.

  • Amphetamine dependence
  • Benzodiazepine dependence
  • Opioid agonist therapy
  • Schizophrenia spectrum disorders

This area combines substance use treatment with psychiatric and metabolic care in complex patient populations.

Infectious Disease, Immune Response, and Supportive Care

Clinical studies include virus diseases, influenza vaccine immunogenicity, and antiviral treatment related to acute COVID and long COVID. The portfolio also includes hypothermia research and hyperbaric oxygen therapy in acute hearing loss, reflecting interest in supportive interventions.

  • Virus diseases
  • Influenza vaccine immunogenicity
  • Long COVID
  • Hypothermia

These studies connect immune-focused research with acute care and symptom-directed interventions across several clinical settings.

Sponsored Trials

Trial Name Country Status
A Multicenter Non-Inferiority Trial Comparing Rituximab and Ocrelizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis Aged 18-60 YearsNorway NorwaySweden SwedenRecruiting
A phase 1/2 multicenter open-label study to investigate treatment of hydroxyurea (HU) in combination with valproic acid (VPA) or 6- mercaptopurine (6-MP) in combination with VPA in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS) considered unfit for standard chemotherapyNorway NorwayRecruiting
A phase 3 randomized, placebo-controlled, triple blind parallel-group study of candesartan in adults with episodic cluster headache (Episodic CandClus2)Denmark DenmarkNorway NorwayNot Yet Recruiting
A phase IV study to investigate the immunogenicity of the Seqirus licensed MF59 adjuvanted zoonotic influenza vaccine (H5N8) in adults previously vaccinated in 2009 with the Matrix M adjuvanted virosomal influenza (H5N1) vaccine compared to H5 naïve adults.Norway NorwayNot Recruiting
Comparative Efficacy and Safety of Autologous Hematopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine, or Ocrelizumab in Relapsing-Remitting Multiple SclerosisDenmark DenmarkNorway NorwaySweden SwedenThe Netherlands The NetherlandsNot Recruiting
Comparative Efficacy and Safety of Sirolimus Versus Methylprednisolone in Patients with Active Thyroid Eye DiseaseNorway NorwayRecruiting
Evaluation of Daratumumab in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled, Double-Blind Phase II TrialNorway NorwayRecruiting
Evaluation of Dexamfetamine Sulfate in Reducing Illicit Amphetamine Use in Adults with Comorbid Amphetamine and Opioid Dependence Undergoing Opioid Agonist TherapyNorway NorwayRecruiting
Evaluation of Diazepam and Oxazepam Stabilization Versus Tapering in Benzodiazepine-Dependent Patients Undergoing Opioid Agonist TherapyNorway NorwayRecruiting
Evaluation of Dose-Dense Cyclophosphamide in Patients with TP53 Mutated or Wild-Type Advanced Breast CancerNorway NorwayNot Recruiting
1–10 of 26
1 / 3

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 50 total (4% not shared with other sponsors)

This sponsor works with 50 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
77%
Return partnership rate
20 of 26 sites collaborated multiple times

This sponsor has worked with 26 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Nervous System Diseases9 trials
    449 other sponsors
  • 2.
    Neoplasms5 trials
    853 other sponsors
  • 3.
    Immune System Diseases3 trials
    322 other sponsors
  • 4.
    Virus Diseases3 trials
    182 other sponsors
  • 5.
    Hormonal diseases2 trials
    89 other sponsors
  • 6.
    Mental Disorders2 trials
    150 other sponsors
  • 7.
    Digestive System Diseases1 trial
    280 other sponsors
  • 8.
    Disorders of Environmental Origin1 trial
    5 other sponsors
  • 9.
    Eye Diseases1 trial
    138 other sponsors
  • 10.
    Nutritional and Metabolic Diseases1 trial
    211 other sponsors
  • 11.
    Otorhinolaryngologic Diseases1 trial
    49 other sponsors
  • 12.
    Physiological processes1 trial
    28 other sponsors

Partnered Research Centres

26 centres
location_city
assignment185
Akershus University Hospital
Address
Sykehusveien 25, 1474 Lorenskog
Learn morearrow_forward
location_city
assignment680
Amsterdam UMC
Address
De Boelelaan 1117, 1081 HV Amsterdam
Learn morearrow_forward
location_city
assignment18
Drammen Sykehus
Address
Dronninggata 28, 3004 Drammen
Learn morearrow_forward
location_city
assignment2
Finnmarkssykehuset HF
Address
Sykehusveien 35, 9601 Hammerfest
Learn morearrow_forward
location_city
assignment231
Helse Bergen HF
Address
Haukelandsveien 22, 5021 Bergen
Learn morearrow_forward
location_city
assignment12
Helse Fonna HF
Address
Karmsundgata 120, 5528 Haugesund
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Helse Bergen HF.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.